Manufacturing Considerations for Successful Gene Therapy Development | Tanner Dockendorf
Presented by Tanner Dockendorf, Senior Manager, GMP Nucleic Acids Business Unit. Presented at the Advanced Therapies Congress & Expo 2020.
When developing a clinical gene therapy program geared for commercial success, planning for plasmid manufacturing early in the process is a critical step. In this presentation, we point out the important considerations to make, starting with the end in mind.
To learn more, visit https://www.aldevron.com/.
#Aldevron #GeneTherapy #AdTherapies2020